Sentinel Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Hold
2,854
0.05% 94
2026
Q1
$563K Sell
2,854
-1
-0% -$193 0.06% 95
2025
Q4
$525K Hold
2,855
0.05% 91
2025
Q3
$438K Buy
+2,855
New +$432K 0.04% 92
2022
Q3
Sell
-2,719
Closed -$359K 112
2022
Q2
$359K Hold
2,719
0.06% 92
2022
Q1
$361K Sell
2,719
-60
-2% -$7.2K 0.04% 102
2021
Q4
$324K Buy
+2,779
New +$327K 0.04% 112

Other funds holding AZN

Sentinel Trust's AZN Position: Q2 2026 in Review

Sentinel Trust held its AstraZeneca (AZN) position steady in Q2 2026 at 2,854 shares worth $541K. The position accounts for 0.05% of the portfolio, ranked #94.

Sentinel Trust first reported a position in AZN in Q4 2021 and has held it in 7 quarters since. The position peaked at $563K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sentinel Trust held 2,854 shares of AstraZeneca worth $541K as of Q2 2026.
  • Sentinel Trust left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.05% of Sentinel Trust's portfolio in Q2 2026, its #94 holding.
  • Sentinel Trust first reported a position in AstraZeneca in Q4 2021 and has held it in 7 quarters since.
  • Sentinel Trust's AstraZeneca position peaked at $563K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.